Palliative Medicine Clinical Trial
Official title:
A Multidimensional Strategy to Improve Quality of Life of Patients With Multiple Symptoms and Palliative Care Needs
A nationwide, cross-sectional study, to determine the prevalence of symptoms of patients in the palliative phase in various care settings will be performed within a set period of two weeks in September 2018 and two weeks in November 2018. The participating settings will be selected by a total of seven coordinators, one for each consortium of palliative care in the Netherlands. To identify common combinations of symptoms and for multidimensional screening the Utrecht Symptom Diary-4 Dimensional (USD-4D) and Utrecht Symptom Diary (USD), a Dutch instrument based on the Edmonton Symptom Assessment Scale, will be used. The current protocol focuses on the cross-sectional study.
The Utrecht Symptom Diary-4 dimensional (USD-4D), a Dutch instrument based on the Edmonton Symptom Assessment Scale, will be used for multidimensional screening and assessment of intensity and prevalence of symptoms. The questionnaire assesses twelve symptoms: pain, sleeping problems, dry mouth, dysphagia, anorexia, constipation, nausea, dyspnoea, fatigue, anxiety, depressed mood and confusion. This is measured on a numeric scale from 0 (no complaints) to 10 (worst imaginable or intolerable). The prevalence of symptoms will be described by frequencies, dichotomizing symptom scores in absent (0 on NRS) or present (1 or higher on NRS). Symptom scores of 4 or higher on NRS are considered clinically relevant. There is a possibility to add two more complaints not enlisted and to prioritise the problems which should be addressed first by the HCP. Quality of life is assessed using a (un)well-being measure and the opportunity to score the experienced value of life. Finally, five multidimensional questions will screen for mental capacity ("draagkracht"), the relationship with loved ones and thoughts concerning end of life. These multidimensional questions will be filled out together with the HCP. Therefore the HCP decides beforehand whether those questions will be asked. The USD-4D will be filled out only once by participating patients without follow-up. The patients will be asked to fill out the following characteristics: age, gender, education level, cultural background, living situation, underlying disease, comorbidities, performance score, medication groups and interventions. The estimated time to fill out both questionnaires is fifteen to twenty-five minutes. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT03245658 -
The Effect of Cannabis in Pancreatic Cancer
|
Phase 2 | |
Not yet recruiting |
NCT06328751 -
Meditation With Virtual Reality for Cancer Pain Relief in the Pain Therapy and Palliative Care Service
|
N/A | |
Recruiting |
NCT05883696 -
Palliative Care Needs Among Elderly People at Emergency Department
|
||
Completed |
NCT01415934 -
Statin Discontinuation in Advanced Illness
|
N/A | |
Recruiting |
NCT04519632 -
Paediatric Palliative Care Pain Management in the Community
|
||
Not yet recruiting |
NCT06110624 -
The MuSt-PC: a Feasibility Study on Intent to Use a Tool With Regard to Symptom Management
|
||
Completed |
NCT04630743 -
Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease
|
N/A | |
Completed |
NCT05454644 -
Effectiveness of a Person-centred Prescription Model at the End of Life
|
N/A | |
Not yet recruiting |
NCT06329856 -
Exploring Indications and Practices of Administering Artificial Hydration to Terminal Cancer Patients in Taiwan
|
||
Terminated |
NCT02581059 -
Efficacy of Ginseng for Patients on Regorafenib
|
Phase 2 | |
Terminated |
NCT04251520 -
The Role of the Pharmacist and Pharmacogenomics in the Care of Seriously Ill Patients
|
N/A | |
Withdrawn |
NCT06310889 -
Evaluation of Palliative Care Co-treatment by Attending Physicians and Nurses: an Online Survey as Part of the Project
|
||
Completed |
NCT05640076 -
Effects of a 24/7 Palliative Care Service Integration in a Metropolitan Area on Non-oncologic Patients
|